Kino Tomoshige, Tsukamoto Makoto, Chrousos George
Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Biochem Biophys Res Commun. 2002 Oct 18;298(1):17-23. doi: 10.1016/s0006-291x(02)02442-7.
The human immunodeficiency virus type-1 (HIV-1)-accessory protein Vpr interacts with and potentiates the activity of the glucocorticoid receptor (GR) and arrests the host cell cycle at the G2/M boundary. Here we report that three core components of the general transcription factor (TF) IIH, CDK7, Cyclin H, and MAT1, enhance Vpr's GR coactivator activity but inhibit its cell cycle-arresting function. A CDK7 mutant defective in kinase activity for the C-terminal tail of RNA polymerase II, which cannot form a functional TFIIH complex, did not enhance Vpr coactivator activity. Overexpression of all three TFIIH components and p300 cooperatively enhanced Vpr coactivator activity, whereas TFIIH overexpression did not potentiate the transcriptional activity of a Vpr mutant, which does not bind p300/CBP. These findings suggest that TFIIH participates in Vpr's GR coactivating activity, at a step beyond its interaction with p300/CBP.
人类免疫缺陷病毒1型(HIV-1)的辅助蛋白Vpr与糖皮质激素受体(GR)相互作用并增强其活性,使宿主细胞周期停滞在G2/M边界。在此,我们报告通用转录因子(TF)IIH的三个核心组分,即CDK7、细胞周期蛋白H和MAT1,增强了Vpr的GR共激活因子活性,但抑制了其细胞周期阻滞功能。一种对RNA聚合酶II C末端尾部激酶活性有缺陷的CDK7突变体,其无法形成功能性的TFIIH复合物,并未增强Vpr共激活因子活性。所有三种TFIIH组分和p300的过表达协同增强了Vpr共激活因子活性,而TFIIH的过表达并未增强不结合p300/CBP的Vpr突变体的转录活性。这些发现表明,TFIIH在其与p300/CBP相互作用之外的一个步骤参与了Vpr的GR共激活活性。